370 related articles for article (PubMed ID: 23446829)
1. Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases.
Vinchi F; De Franceschi L; Ghigo A; Townes T; Cimino J; Silengo L; Hirsch E; Altruda F; Tolosano E
Circulation; 2013 Mar; 127(12):1317-29. PubMed ID: 23446829
[TBL] [Abstract][Full Text] [Related]
2. Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress.
Ingoglia G; Sag CM; Rex N; De Franceschi L; Vinchi F; Cimino J; Petrillo S; Wagner S; Kreitmeier K; Silengo L; Altruda F; Maier LS; Hirsch E; Ghigo A; Tolosano E
Free Radic Biol Med; 2017 Jul; 108():452-464. PubMed ID: 28400318
[TBL] [Abstract][Full Text] [Related]
3. Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease.
Vinchi F; Costa da Silva M; Ingoglia G; Petrillo S; Brinkman N; Zuercher A; Cerwenka A; Tolosano E; Muckenthaler MU
Blood; 2016 Jan; 127(4):473-86. PubMed ID: 26675351
[TBL] [Abstract][Full Text] [Related]
4. Sickle cell disease: role of reactive oxygen and nitrogen metabolites.
Wood KC; Granger DN
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):926-32. PubMed ID: 17645642
[TBL] [Abstract][Full Text] [Related]
5. Different target specificities of haptoglobin and hemopexin define a sequential protection system against vascular hemoglobin toxicity.
Deuel JW; Vallelian F; Schaer CA; Puglia M; Buehler PW; Schaer DJ
Free Radic Biol Med; 2015 Dec; 89():931-43. PubMed ID: 26475040
[TBL] [Abstract][Full Text] [Related]
6. Hemopexin prevents endothelial damage and liver congestion in a mouse model of heme overload.
Vinchi F; Gastaldi S; Silengo L; Altruda F; Tolosano E
Am J Pathol; 2008 Jul; 173(1):289-99. PubMed ID: 18556779
[TBL] [Abstract][Full Text] [Related]
7. Defective recovery and severe renal damage after acute hemolysis in hemopexin-deficient mice.
Tolosano E; Hirsch E; Patrucco E; Camaschella C; Navone R; Silengo L; Altruda F
Blood; 1999 Dec; 94(11):3906-14. PubMed ID: 10572107
[TBL] [Abstract][Full Text] [Related]
8. Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.
Belcher JD; Chen C; Nguyen J; Abdulla F; Zhang P; Nguyen H; Nguyen P; Killeen T; Miescher SM; Brinkman N; Nath KA; Steer CJ; Vercellotti GM
PLoS One; 2018; 13(4):e0196455. PubMed ID: 29694434
[TBL] [Abstract][Full Text] [Related]
9. Sickle cell disease vasculopathy: a state of nitric oxide resistance.
Wood KC; Hsu LL; Gladwin MT
Free Radic Biol Med; 2008 Apr; 44(8):1506-28. PubMed ID: 18261470
[TBL] [Abstract][Full Text] [Related]
10. Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis.
Day SM; Duquaine D; Mundada LV; Menon RG; Khan BV; Rajagopalan S; Fay WP
Circulation; 2003 May; 107(20):2601-6. PubMed ID: 12732602
[TBL] [Abstract][Full Text] [Related]
11. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y
Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904
[TBL] [Abstract][Full Text] [Related]
12. Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.
Kaul DK; Zhang X; Dasgupta T; Fabry ME
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H39-47. PubMed ID: 18456737
[TBL] [Abstract][Full Text] [Related]
13. Role of hemoglobin/heme scavenger protein hemopexin in atherosclerosis and inflammatory diseases.
Mehta NU; Reddy ST
Curr Opin Lipidol; 2015 Oct; 26(5):384-7. PubMed ID: 26339767
[TBL] [Abstract][Full Text] [Related]
14. Intravenous infusion of haptoglobin for the prevention of adverse clinical outcome in Sickle Cell Disease.
Quimby KR; Hambleton IR; Landis RC
Med Hypotheses; 2015 Oct; 85(4):424-32. PubMed ID: 26141635
[TBL] [Abstract][Full Text] [Related]
15. Sickle cell anemia and vascular dysfunction: the nitric oxide connection.
Akinsheye I; Klings ES
J Cell Physiol; 2010 Sep; 224(3):620-5. PubMed ID: 20578237
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunction.
Paneni F; Osto E; Costantino S; Mateescu B; Briand S; Coppolino G; Perna E; Mocharla P; Akhmedov A; Kubant R; Rohrer L; Malinski T; Camici GG; Matter CM; Mechta-Grigoriou F; Volpe M; Lüscher TF; Cosentino F
Circulation; 2013 Mar; 127(11):1229-40, e1-21. PubMed ID: 23410942
[TBL] [Abstract][Full Text] [Related]
17. Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles.
Merle NS; Grunenwald A; Rajaratnam H; Gnemmi V; Frimat M; Figueres ML; Knockaert S; Bouzekri S; Charue D; Noe R; Robe-Rybkine T; Le-Hoang M; Brinkman N; Gentinetta T; Edler M; Petrillo S; Tolosano E; Miescher S; Le Jeune S; Houillier P; Chauvet S; Rabant M; Dimitrov JD; Fremeaux-Bacchi V; Blanc-Brude OP; Roumenina LT
JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925688
[TBL] [Abstract][Full Text] [Related]
18. Assessment of total and unbound cell-free heme in plasma of patients with sickle cell disease.
Vissa M; Larkin SK; Vichinsky EP; Kuypers FA; Soupene E
Exp Biol Med (Maywood); 2023 May; 248(10):897-907. PubMed ID: 36941786
[TBL] [Abstract][Full Text] [Related]
19. Heme-mediated reactive oxygen species toxicity to retinal pigment epithelial cells is reduced by hemopexin.
Hunt RC; Handy I; Smith A
J Cell Physiol; 1996 Jul; 168(1):81-6. PubMed ID: 8647926
[TBL] [Abstract][Full Text] [Related]
20. Endothelial dysfunction inhibits the ability of haptoglobin to prevent hemoglobin-induced hypertension.
Graw JA; Yu B; Rezoagli E; Warren HS; Buys ES; Bloch DB; Zapol WM
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1120-H1127. PubMed ID: 28314763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
